Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo
Benjamin Ellingson, Lauren Abrey, Josep Garcia, Olivier Chinot, Wolfgang Wick, et al.. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro-Oncology, Oxford University Press (OUP), 2018, ⟨10.1093/neuonc/noy064⟩. ⟨hal-01858243⟩